AUSTIN, Texas--(BUSINESS WIRE)--CDISC announces industry veteran Chris Decker is joining the organization as its new President and Chief Executive Officer effective January 2, 2024, succeeding Dave ...

AUSTIN, Texas--(BUSINESS WIRE)--Resource savings of 60% overall (80% in the start-up stage) can be reaped in a clinical research study with the implementation of standards developed by the Clinical ...

The Clinical Data Interchange Standards Consortium ( is a global, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and ...

As always, CDISC begins the year with a flurry of activity (do keep an eye on the website for regular updates and news on the standards). In addition to the CDISC standards themselves, the CDISC Board ...

The clinical trial process is a long, expensive, complicated one that often ends in failure. This means that to have a successful outcome, careful decision making and planning are absolutely essential ...

The Clinical Data Interchange Standards Consortium (CDISC) and the Infectious Diseases Data Observatory (IDDO) announce the availability of a new standard to assist in the collection, aggregation and ...

The Innovative Medicines Initiative (IMI) has announced an agreement with the US-based Clinical Data Interchange Standards Consortium (CDISC) that will see IMI project teams adopt CDISC formats and ...

CDISC is pleased to announce that three highly- qualified individuals have joined its Board of Directors, each for a three year term (2011-2013). Following a rigorous process of selection, CDISC is ...

The Clinical Data Interchange Standards Consortium (CDISC) is a global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission ...

CDISC and the National Organization for Rare Disorders (NORD ®) have announced a partnership to develop global data standards for rare diseases. The data standards will be released in a Therapeutic ...

CDISC today announced three members have joined its Board of Directors: Jonathan Chainey, Dominic Labriola and Rhona O'Donnell each began serving a three-year term at the beginning of the year.